Table 9.
Comparison of assessment parameters before the applications and at the end of the 3-year follow-up period between 4 groups.
| To-T1 | Wj-Msc1 | Magnovision2 | Wj-Msc + Magnovision3 | Control4 | P*** | Difference** |
|---|---|---|---|---|---|---|
| X ± s.s. | X ± s.s. | X ± s.s. | X ± s.s. | |||
| ΔHorizontal EZW | 0.20 ± 0.05 | 0.34 ± 0.08 | 0.04 ± 0.01 | 0.86 ± 0.21 | 0.01* | 4 > 1.2 > 3 |
| ΔVertical EZW | 0.20 ± 0.04 | 0.35 ± 0.09 | 0.07 ± 0.02 | 0.80 ± 0.22 | 0.03* | 4 > 1.2 > 3 |
| ΔFAF field | 0.39 ± 0.11 | 1.50 ± 0.41 | 0.07 ± 0.02 | 3.76 ± 1.02 | 0.01* | 4 > 2 > 1 > 3 |
| ΔBCVA | 3.59 ± 0.97 | 4.84 ± 1.31 | −0.16 ± -0.04 | 12.04 ± 3.25 | 0.01* | 4 > 1.2 > 3 |
| ΔFPDI | 0.50 ± 0.14 | 2.66 ± 0.72 | 0.01 ± 0.00 | 7.25 ± 1.96 | 0.01* | 4 > 2 > 1 > 3 |
| ΔERG magnitude | −0.01 ± 0.00 | −0.04 ± −0.01 | −0.14 ± -0.04 | 0.06 ± 0.02 | 0.02* | 3 > 1,2,4 |
***Kruskall-Wallis test; **Mann-Whitney U test; *0.05 statistically significant.
BCVA, best corrected visual acuity, (ETDRS letters); ERG magnitudes, full field flicker electroretinography magnitudes (mV); EZW, ellipsoid zone width (mm); FAF, fundus autofluorescence (mm2); FPDI, Fundus perimetry deviation index (%).